Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AK160 (Xiaflex) in Japanese Patients with Dupuytren's Contracture
NCT01588353Phase 3Completed
- Sponsor
- Asahi Kasei Corporation
- Start
- May 2012
- Primary completion
- Jan 2014
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of collagenase clostridium histolyticum in Dupuytren's contracture, sponsored by Asahi Kasei Corporation. Started May 2012; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Dupuytren's contracture
Beyond the preview
Go deeper on NCT01588353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01588353.